Literature DB >> 21461851

Superoxide release in juvenile systemic lupus erythematosus.

Roberto Marini1, Antonio Condino-Neto, Simone Appenzeller, André M Morcillo, Lilian T L Costallat.   

Abstract

The objective of this study was to analyze the un-stimulated and stimulated release of superoxide anion (O(2) (-)) by granulocytes and monocytes in juvenile systemic lupus erythematosus (jSLE). The un-stimulated and phorbol myristate acetate (PMA, 30 nM)-induced O(2) (-)by granulocytes and monocytes were determined in six different times of incubation in patients with 23 jSLE and 28 controls. The analysis compared the jSLE group, which was classified into two subgroups by SLEDAI in one inactive subgroup (score <3) (n = 13 patients) and one active subgroup (score ≥3) (n = 10 patients) to the same control group. At time of blood withdrawal, 13 (56.52%) had inactive and 10 (43.47%) patients had active SLE. jSLE patients' granulocytes and monocytes had always a lower un-stimulated O(2) (-) production when compared to controls. Stimulated granulocytes had an increased O(2) (-) production at baseline followed by a significant lower production at 60 min in jSLE when compared to controls. Stimulated monocytes had a similar O(2) (-) production among patients with jSLE and controls. The results suggest a defect in phagocytic function in jSLE. The significant higher release of O(2) (-) in the assays of the stimulated granulocytes, in the initial instances, the so-called respiratory burst, could be attributed to the inflammatory state of phagocytes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21461851     DOI: 10.1007/s00296-011-1918-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  29 in total

1.  Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; R Hartung; H Kroeger
Journal:  Inflammation       Date:  1996-08       Impact factor: 4.092

2.  Scavengers of free radical oxygen affect the generation of low molecular weight DNA in stimulated lymphocytes from patients with systemic lupus erythematosus.

Authors:  P J Benke; H Levcovitz; J Paupe; E Tozman
Journal:  Metabolism       Date:  1990-12       Impact factor: 8.694

3.  Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.

Authors:  A G Stewart; P N Dubbin; T Harris; G J Dusting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

4.  Triggering of respiratory burst by phagocytosis in monocytes of patients with systemic lupus erythematosus.

Authors:  E Gyimesi; M Kavai; E Kiss; I Csipö; G Szücs; G Szegedi
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

5.  Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986.

Authors:  E N Harris; A E Gharavi; S P Patel; G R Hughes
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

6.  Monocytes of patients wiht systemic sclerosis (scleroderma spontaneously release in vitro increased amounts of superoxide anion.

Authors:  P Sambo; L Jannino; M Candela; A Salvi; M Donini; S Dusi; M M Luchetti; A Gabrielli
Journal:  J Invest Dermatol       Date:  1999-01       Impact factor: 8.551

7.  Binding of C-reactive protein to human neutrophils. Inhibition of respiratory burst activity.

Authors:  R Dobrinich; P J Spagnuolo
Journal:  Arthritis Rheum       Date:  1991-08

8.  Age-related changes in neutrophil structure and function.

Authors:  M H Perskin; B N Cronstein
Journal:  Mech Ageing Dev       Date:  1992-07-15       Impact factor: 5.432

9.  Age-associated changes of neutrophil responsiveness in a human healthy elderly population.

Authors:  A Polignano; C Tortorella; A Venezia; E Jirillo; S Antonaci
Journal:  Cytobios       Date:  1994

10.  Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.

Authors:  E Waszczykowska; E Robak; A Wozniacka; J Narbutt; J D Torzecka; A Sysa-Jedrzejowska
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.